Automated mapping of body surface and pericardial potentials in experimental myocardial infarction. Reduction of infarct size by means of a new beta-adrenolytic compound.
D000818:Animals; D004285:Dogs; D004562:Electrocardiography / Q000379:methods*; D006329:Heart Conduction System / Q000502:physiology; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology*; D010496:Pericardium / Q000503:physiopathology; D011433:Propranolol / Q000627:therapeutic use*
D011433:Propranolol